Scientific Frontiers abstract deadline extended for IPA World Congress + Probiota

By Stephen Daniells

- Last updated on GMT

Scientific Frontiers abstract deadline extended for IPA World Congress + Probiota

Related tags Probiota Scientific Frontiers Prebiotics Probiotics microbiome Gut health immune support Unmetered

The deadline for submissions for the Scientific Frontiers session at the upcoming IPA World Congress + Probiota has been extended to 11 November 2022!

If you are researching the latest state-of-the-art developments related to prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry, then we would like to hear from you!

The IPA World Congress + Probiota, which will take place 6-8 February 2023 in Barcelona, is calling for submission of abstracts for next year’s event. Don’t miss your chance to present!

Our Scientific Frontiers​ cover the latest state-of-the-art developments related to prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry.

All abstract submissions will be reviewed by our Scientific Committee made up of leading experts from the fields of pre- and probiotics. All accepted abstracts will be invited to present a poster at our event in Barcelona., while the winning abstract will be invited to give a presentation during the IPA World Congress + Probiota​.

We are particularly interested in reports from human intervention studies and welcome abstracts from those engaged in all aspects of microbiome science in academia, industry and consumer health, particularly those representing successful academia-industry interactions.

Abstracts

Early-phase, novel, or state-of-the-art research or promising ideas covering the following topics are encouraged:

- Host-microbe interactions in health and disease, including preclinical and clinical studies evaluating pre- and probiotic interventions

- Application and development of “-omics” approaches in biomarker discovery, including identification of potential pre- and probiotic strains. Research identifying strain-specific effects of probiotics for health and wellbeing, including mechanism of action and bioactive discovery and isolation

- Early findings from large scale research projects and clinical trials

- Innovations and novel ideas in the areas of production processes, delivery, formulation and shelf-life

- Consumer and market insights, including population research, trends and threats, commercial packaging and marketing

- Human intervention studies

To download a copy of the abstract guidelines, please click HERE​.        

Related news

Related products

show more

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

Your expert partner in active nutrition solutions

Your expert partner in active nutrition solutions

Content provided by ADM | 30-Apr-2024 | Case Study

The intersection of the rising plant-based trend and increasing awareness of gut health has opened new opportunities for market success. Consumer demand...

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Related suppliers

Follow us

Products

View more

Webinars